After-Hours Earnings Report for July 13, 2012 : PDLI

By
A A A

The following companies are expected to report earnings after hours on 07/13/2012. Visit our Earnings Calendar for a full list of expected earnings releases.

PDL BioPharma, Inc. ( PDLI ) is reporting for the quarter ending June 30, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.46. This value represents a 17.95% increase compared to the same quarter last year. PDLI missed the consensus earnings per share in the 2nd calendar quarter by -2.5%. The "days to cover" for this stock exceeds 11 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for PDLI is 4.75 vs. an industry ratio of 16.80.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , Earnings

Referenced Stocks: PDLI

NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

The Pumpkin Carvers
The Pumpkin Carvers                 

Stocks

Referenced

100%

Most Active by Volume

88,066,694
  • $97.19 ▲ 2.61%
58,241,731
  • $71.29 ▲ 2.92%
51,058,864
  • $44.87 ▲ 0.09%
48,927,829
  • $28.75 ▲ 0.81%
46,551,917
    $15.52 unch
40,249,498
  • $3.46 ▼ 0.57%
38,633,031
  • $22.43 ▼ 9.63%
38,240,825
  • $34.71 ▲ 3.30%
As of 7/23/2014, 04:04 PM